| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Leukemia, Myeloid, Acute | 16 | 2025 | 614 | 2.800 |
Why?
|
| STAT3 Transcription Factor | 8 | 2021 | 229 | 1.770 |
Why?
|
| STAT5 Transcription Factor | 3 | 2021 | 93 | 1.070 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 4 | 2021 | 91 | 0.890 |
Why?
|
| Antineoplastic Agents | 8 | 2026 | 1826 | 0.780 |
Why?
|
| Apoptosis | 8 | 2020 | 1827 | 0.740 |
Why?
|
| Interleukin-10 | 1 | 2022 | 192 | 0.670 |
Why?
|
| MAP Kinase Signaling System | 1 | 2021 | 300 | 0.600 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 3 | 2026 | 103 | 0.560 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 3 | 2024 | 81 | 0.560 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2021 | 484 | 0.550 |
Why?
|
| Gene Rearrangement | 3 | 2016 | 323 | 0.480 |
Why?
|
| Transcriptome | 3 | 2021 | 1103 | 0.450 |
Why?
|
| Cysteine-Rich Protein 61 | 1 | 2015 | 6 | 0.450 |
Why?
|
| Mitoxantrone | 1 | 2015 | 28 | 0.450 |
Why?
|
| Enzyme Inhibitors | 2 | 2016 | 573 | 0.430 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2021 | 821 | 0.430 |
Why?
|
| Methyltransferases | 2 | 2016 | 78 | 0.420 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2015 | 219 | 0.410 |
Why?
|
| Quinolines | 2 | 2026 | 118 | 0.410 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2015 | 588 | 0.360 |
Why?
|
| Neoplasm Proteins | 1 | 2015 | 680 | 0.330 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2026 | 633 | 0.310 |
Why?
|
| Recurrence | 3 | 2025 | 1489 | 0.310 |
Why?
|
| Aniline Compounds | 2 | 2026 | 27 | 0.290 |
Why?
|
| Signal Transduction | 4 | 2019 | 4686 | 0.290 |
Why?
|
| Child, Preschool | 14 | 2026 | 15110 | 0.290 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2022 | 639 | 0.290 |
Why?
|
| Cell Line, Tumor | 8 | 2021 | 3748 | 0.280 |
Why?
|
| Nitriles | 2 | 2026 | 163 | 0.280 |
Why?
|
| Receptors, Opioid, kappa | 6 | 2000 | 22 | 0.270 |
Why?
|
| Naphthalenes | 2 | 2020 | 37 | 0.270 |
Why?
|
| Child | 17 | 2026 | 26341 | 0.270 |
Why?
|
| Myelopoiesis | 1 | 2007 | 9 | 0.260 |
Why?
|
| Infant | 11 | 2026 | 13352 | 0.260 |
Why?
|
| Histone-Lysine N-Methyltransferase | 3 | 2024 | 167 | 0.250 |
Why?
|
| Immunophenotyping | 2 | 2025 | 332 | 0.250 |
Why?
|
| Adolescent | 15 | 2026 | 20987 | 0.250 |
Why?
|
| Myeloid Cells | 1 | 2007 | 113 | 0.250 |
Why?
|
| Interleukin-6 | 2 | 2022 | 412 | 0.240 |
Why?
|
| Immunotherapy | 2 | 2025 | 768 | 0.230 |
Why?
|
| Up-Regulation | 2 | 2021 | 825 | 0.230 |
Why?
|
| Hippocampus | 7 | 1996 | 806 | 0.230 |
Why?
|
| Sulfonamides | 2 | 2020 | 296 | 0.230 |
Why?
|
| Neutrophils | 1 | 2007 | 371 | 0.220 |
Why?
|
| Candida tropicalis | 1 | 2024 | 17 | 0.210 |
Why?
|
| Candidiasis, Invasive | 1 | 2024 | 24 | 0.210 |
Why?
|
| Translocation, Genetic | 2 | 2018 | 344 | 0.210 |
Why?
|
| Leukemia, Myeloid, Chronic-Phase | 1 | 2023 | 11 | 0.200 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2018 | 236 | 0.200 |
Why?
|
| Prognosis | 5 | 2024 | 4886 | 0.200 |
Why?
|
| Benzeneacetamides | 3 | 2000 | 5 | 0.200 |
Why?
|
| Antifungal Agents | 1 | 2024 | 292 | 0.180 |
Why?
|
| Gene Expression Regulation, Leukemic | 3 | 2018 | 70 | 0.170 |
Why?
|
| Cell Differentiation | 2 | 2018 | 1928 | 0.170 |
Why?
|
| Models, Biological | 1 | 2026 | 1371 | 0.170 |
Why?
|
| Culture Media, Conditioned | 1 | 2021 | 81 | 0.170 |
Why?
|
| Humans | 27 | 2026 | 131163 | 0.170 |
Why?
|
| Male | 23 | 2026 | 64957 | 0.170 |
Why?
|
| Single-Cell Analysis | 1 | 2024 | 350 | 0.170 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2021 | 67 | 0.170 |
Why?
|
| Hematologic Neoplasms | 1 | 2024 | 315 | 0.170 |
Why?
|
| Interleukin-13 | 1 | 2021 | 97 | 0.160 |
Why?
|
| Cryopreservation | 1 | 2021 | 79 | 0.160 |
Why?
|
| Dentate Gyrus | 3 | 2000 | 37 | 0.160 |
Why?
|
| Atovaquone | 1 | 2019 | 11 | 0.150 |
Why?
|
| Sarcoma, Myeloid | 1 | 2019 | 10 | 0.150 |
Why?
|
| Proportional Hazards Models | 2 | 2021 | 1410 | 0.150 |
Why?
|
| Interleukin-15 | 1 | 2020 | 104 | 0.150 |
Why?
|
| Pyrrolidines | 3 | 2000 | 49 | 0.150 |
Why?
|
| Transcriptional Activation | 1 | 2021 | 419 | 0.150 |
Why?
|
| Guinea Pigs | 7 | 2000 | 147 | 0.150 |
Why?
|
| Oxidative Phosphorylation | 1 | 2019 | 142 | 0.140 |
Why?
|
| Female | 16 | 2026 | 70963 | 0.140 |
Why?
|
| Long-Term Potentiation | 3 | 2000 | 103 | 0.140 |
Why?
|
| Dihydroergotamine | 1 | 2018 | 9 | 0.140 |
Why?
|
| Cytokines | 2 | 2022 | 1339 | 0.140 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2018 | 33 | 0.140 |
Why?
|
| Phosphorylation | 2 | 2012 | 1571 | 0.140 |
Why?
|
| Sequence Analysis, RNA | 1 | 2021 | 407 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2018 | 77 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2018 | 87 | 0.130 |
Why?
|
| Multivariate Analysis | 1 | 2021 | 1378 | 0.130 |
Why?
|
| Mice, Inbred NOD | 4 | 2020 | 299 | 0.130 |
Why?
|
| Dynorphins | 3 | 2000 | 10 | 0.130 |
Why?
|
| Vasoconstrictor Agents | 1 | 2018 | 136 | 0.130 |
Why?
|
| Young Adult | 4 | 2025 | 10103 | 0.130 |
Why?
|
| Animals | 22 | 2020 | 33912 | 0.130 |
Why?
|
| Flow Cytometry | 2 | 2024 | 765 | 0.120 |
Why?
|
| Drug Delivery Systems | 1 | 2018 | 224 | 0.120 |
Why?
|
| Interleukin-3 Receptor alpha Subunit | 1 | 2016 | 11 | 0.120 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 713 | 0.120 |
Why?
|
| Rhodium | 1 | 2015 | 4 | 0.120 |
Why?
|
| Histone Demethylases | 1 | 2016 | 41 | 0.120 |
Why?
|
| Glucocorticoids | 1 | 2018 | 348 | 0.110 |
Why?
|
| Cell Proliferation | 5 | 2018 | 2465 | 0.110 |
Why?
|
| Ikaros Transcription Factor | 1 | 2015 | 34 | 0.110 |
Why?
|
| Syk Kinase | 1 | 2015 | 17 | 0.110 |
Why?
|
| Cell Survival | 3 | 2019 | 826 | 0.110 |
Why?
|
| Transcription Factors | 1 | 2005 | 2406 | 0.110 |
Why?
|
| Blotting, Western | 3 | 2016 | 1013 | 0.110 |
Why?
|
| Synapses | 2 | 2000 | 425 | 0.110 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2021 | 1280 | 0.110 |
Why?
|
| Disease-Free Survival | 2 | 2017 | 905 | 0.110 |
Why?
|
| HL-60 Cells | 1 | 2014 | 31 | 0.110 |
Why?
|
| Tumor Cells, Cultured | 2 | 2018 | 975 | 0.110 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2019 | 1011 | 0.100 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 1801 | 0.100 |
Why?
|
| Synaptic Transmission | 2 | 1997 | 299 | 0.100 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2014 | 18 | 0.100 |
Why?
|
| Histones | 2 | 2016 | 541 | 0.100 |
Why?
|
| Neural Inhibition | 2 | 1994 | 107 | 0.100 |
Why?
|
| Endorphins | 2 | 1994 | 6 | 0.100 |
Why?
|
| Stromal Cells | 1 | 2015 | 316 | 0.100 |
Why?
|
| Filgrastim | 1 | 2012 | 13 | 0.100 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2020 | 960 | 0.100 |
Why?
|
| Mice | 10 | 2020 | 18301 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2016 | 1205 | 0.090 |
Why?
|
| Leukemia | 1 | 2016 | 387 | 0.090 |
Why?
|
| Cell Separation | 1 | 2012 | 218 | 0.090 |
Why?
|
| Mice, SCID | 3 | 2018 | 585 | 0.090 |
Why?
|
| Radiation Dosage | 1 | 2012 | 132 | 0.090 |
Why?
|
| Cell Cycle | 1 | 2014 | 594 | 0.090 |
Why?
|
| Adult | 5 | 2026 | 31282 | 0.090 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2015 | 722 | 0.080 |
Why?
|
| Homeodomain Proteins | 1 | 2014 | 555 | 0.080 |
Why?
|
| DNA Damage | 1 | 2014 | 511 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2026 | 1618 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 2026 | 0.080 |
Why?
|
| Positron-Emission Tomography | 1 | 2012 | 279 | 0.080 |
Why?
|
| Nerve Fibers | 2 | 2000 | 65 | 0.080 |
Why?
|
| Ligands | 1 | 2011 | 481 | 0.080 |
Why?
|
| Protein Isoforms | 2 | 2007 | 423 | 0.070 |
Why?
|
| Recombinant Proteins | 1 | 2012 | 1319 | 0.070 |
Why?
|
| Hodgkin Disease | 1 | 2012 | 307 | 0.070 |
Why?
|
| Survival Analysis | 1 | 2012 | 1483 | 0.070 |
Why?
|
| Axons | 3 | 2000 | 386 | 0.070 |
Why?
|
| Neurons | 3 | 2000 | 1979 | 0.070 |
Why?
|
| Dendrites | 2 | 2000 | 180 | 0.070 |
Why?
|
| Pilocarpine | 1 | 1997 | 10 | 0.070 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2020 | 114 | 0.070 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2015 | 895 | 0.070 |
Why?
|
| T-Lymphocytes | 1 | 2016 | 1722 | 0.060 |
Why?
|
| Neoplasms, Experimental | 2 | 2020 | 201 | 0.060 |
Why?
|
| Structure-Activity Relationship | 2 | 2020 | 552 | 0.060 |
Why?
|
| Elapid Venoms | 1 | 1996 | 9 | 0.060 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 1997 | 92 | 0.060 |
Why?
|
| Membrane Transport Proteins | 1 | 2007 | 180 | 0.060 |
Why?
|
| Disease Models, Animal | 4 | 2020 | 4697 | 0.060 |
Why?
|
| Presynaptic Terminals | 1 | 1996 | 74 | 0.060 |
Why?
|
| Cell Line | 2 | 2007 | 2552 | 0.060 |
Why?
|
| Potassium Channels | 1 | 1996 | 154 | 0.060 |
Why?
|
| RNA, Messenger | 1 | 2011 | 2550 | 0.060 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2005 | 7 | 0.060 |
Why?
|
| Cell Nucleus | 1 | 2007 | 556 | 0.050 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2007 | 289 | 0.050 |
Why?
|
| Adenylyl Cyclases | 1 | 1995 | 45 | 0.050 |
Why?
|
| Drug Resistance, Fungal | 1 | 2024 | 31 | 0.050 |
Why?
|
| Risk Factors | 2 | 2024 | 11074 | 0.050 |
Why?
|
| Milk Proteins | 1 | 2005 | 95 | 0.050 |
Why?
|
| Calcium Channels | 1 | 1995 | 143 | 0.050 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2005 | 90 | 0.050 |
Why?
|
| Karyotyping | 2 | 2015 | 308 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2012 | 2065 | 0.050 |
Why?
|
| Granulocytes | 1 | 1994 | 69 | 0.050 |
Why?
|
| Administration, Oral | 1 | 2026 | 711 | 0.050 |
Why?
|
| Drug Design | 1 | 2005 | 156 | 0.050 |
Why?
|
| Neurotransmitter Agents | 1 | 1994 | 134 | 0.050 |
Why?
|
| Glutamic Acid | 1 | 1994 | 200 | 0.050 |
Why?
|
| Cell Lineage | 1 | 2025 | 349 | 0.050 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2015 | 743 | 0.050 |
Why?
|
| NF-kappa B | 1 | 2005 | 440 | 0.050 |
Why?
|
| Norepinephrine | 1 | 1992 | 149 | 0.040 |
Why?
|
| Analgesics | 3 | 2000 | 120 | 0.040 |
Why?
|
| Learning | 1 | 1995 | 356 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2024 | 859 | 0.040 |
Why?
|
| In Vitro Techniques | 3 | 2000 | 808 | 0.040 |
Why?
|
| Trans-Activators | 1 | 2005 | 697 | 0.040 |
Why?
|
| Brain Chemistry | 1 | 1991 | 110 | 0.040 |
Why?
|
| Aspartic Acid | 1 | 1991 | 72 | 0.040 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2019 | 34 | 0.040 |
Why?
|
| Computational Biology | 1 | 2024 | 862 | 0.040 |
Why?
|
| Oxidation-Reduction | 1 | 2020 | 436 | 0.040 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2020 | 174 | 0.040 |
Why?
|
| Nuclear Proteins | 1 | 2005 | 1211 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2024 | 8635 | 0.030 |
Why?
|
| Molecular Targeted Therapy | 1 | 2020 | 386 | 0.030 |
Why?
|
| Brain | 2 | 1995 | 3175 | 0.030 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2018 | 105 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2020 | 1064 | 0.030 |
Why?
|
| Incidence | 1 | 2024 | 3360 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2005 | 1939 | 0.030 |
Why?
|
| Kinetics | 3 | 2007 | 1088 | 0.030 |
Why?
|
| Dexamethasone | 1 | 2018 | 250 | 0.030 |
Why?
|
| U937 Cells | 1 | 2016 | 22 | 0.030 |
Why?
|
| Antigens, CD20 | 1 | 2016 | 44 | 0.030 |
Why?
|
| Genes, Transgenic, Suicide | 1 | 2016 | 48 | 0.030 |
Why?
|
| Monoamine Oxidase Inhibitors | 1 | 2016 | 13 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2024 | 17753 | 0.030 |
Why?
|
| Complement System Proteins | 1 | 2016 | 58 | 0.030 |
Why?
|
| Protein Binding | 1 | 2020 | 1652 | 0.030 |
Why?
|
| CD3 Complex | 1 | 2016 | 96 | 0.030 |
Why?
|
| Retroviridae | 1 | 2016 | 182 | 0.030 |
Why?
|
| Methylation | 1 | 2016 | 199 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2016 | 237 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2016 | 209 | 0.030 |
Why?
|
| Lysine | 1 | 2016 | 167 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2016 | 276 | 0.030 |
Why?
|
| Catalysis | 1 | 2015 | 136 | 0.030 |
Why?
|
| Neoplastic Stem Cells | 1 | 2018 | 330 | 0.030 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2016 | 272 | 0.030 |
Why?
|
| RNA, Long Noncoding | 1 | 2018 | 218 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2016 | 315 | 0.030 |
Why?
|
| Evoked Potentials | 2 | 1996 | 113 | 0.030 |
Why?
|
| Rituximab | 1 | 2016 | 170 | 0.030 |
Why?
|
| Microscopy, Electron | 2 | 1996 | 305 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 1991 | 981 | 0.030 |
Why?
|
| Leukocytosis | 1 | 2014 | 46 | 0.030 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 2014 | 66 | 0.020 |
Why?
|
| Antibody Specificity | 2 | 1996 | 164 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2014 | 143 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2015 | 516 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 757 | 0.020 |
Why?
|
| Binding Sites | 1 | 2015 | 1133 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2016 | 892 | 0.020 |
Why?
|
| DNA | 1 | 2018 | 1399 | 0.020 |
Why?
|
| Peptides | 2 | 1996 | 708 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 1295 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 992 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2014 | 363 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2016 | 544 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 1996 | 1591 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2019 | 3819 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 526 | 0.020 |
Why?
|
| Dipeptidases | 1 | 1990 | 15 | 0.020 |
Why?
|
| Rats | 3 | 1997 | 3370 | 0.020 |
Why?
|
| Middle Aged | 2 | 2025 | 28601 | 0.020 |
Why?
|
| 2-Amino-5-phosphonovalerate | 1 | 2000 | 14 | 0.020 |
Why?
|
| Receptors, GABA-A | 1 | 2000 | 57 | 0.020 |
Why?
|
| Calcium | 2 | 1995 | 1010 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 1882 | 0.020 |
Why?
|
| Mutation | 2 | 2015 | 6099 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2023 | 12936 | 0.020 |
Why?
|
| Luciferases | 1 | 2007 | 127 | 0.020 |
Why?
|
| Rats, Inbred Strains | 2 | 1991 | 181 | 0.020 |
Why?
|
| Aged | 1 | 2025 | 21025 | 0.020 |
Why?
|
| Tetraethylammonium Compounds | 1 | 1996 | 3 | 0.020 |
Why?
|
| Bee Venoms | 1 | 1996 | 6 | 0.020 |
Why?
|
| Nerve Endings | 1 | 1996 | 6 | 0.020 |
Why?
|
| Tetraethylammonium | 1 | 1996 | 10 | 0.020 |
Why?
|
| 4-Aminopyridine | 1 | 1996 | 28 | 0.020 |
Why?
|
| Barium | 1 | 1996 | 13 | 0.020 |
Why?
|
| Glyburide | 1 | 1996 | 22 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2007 | 358 | 0.020 |
Why?
|
| Xenopus laevis | 1 | 1996 | 112 | 0.010 |
Why?
|
| Neurotoxins | 1 | 1996 | 44 | 0.010 |
Why?
|
| Shaker Superfamily of Potassium Channels | 1 | 1996 | 31 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2007 | 716 | 0.010 |
Why?
|
| omega-Conotoxin GVIA | 1 | 1995 | 7 | 0.010 |
Why?
|
| Isradipine | 1 | 1995 | 7 | 0.010 |
Why?
|
| Nifedipine | 1 | 1995 | 22 | 0.010 |
Why?
|
| Calcium Channel Blockers | 1 | 1995 | 107 | 0.010 |
Why?
|
| Naltrexone | 1 | 1995 | 68 | 0.010 |
Why?
|
| Genomic Library | 1 | 1995 | 35 | 0.010 |
Why?
|
| Mice, Neurologic Mutants | 1 | 1995 | 74 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1995 | 167 | 0.010 |
Why?
|
| Afferent Pathways | 1 | 1994 | 10 | 0.010 |
Why?
|
| Autoradiography | 1 | 1994 | 61 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1997 | 1105 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1994 | 73 | 0.010 |
Why?
|
| Dominance, Cerebral | 1 | 1994 | 49 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1996 | 787 | 0.010 |
Why?
|
| Oocytes | 1 | 1996 | 283 | 0.010 |
Why?
|
| Brain Stem | 1 | 1995 | 108 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 1995 | 220 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1994 | 358 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2007 | 849 | 0.010 |
Why?
|
| Radioligand Assay | 1 | 1992 | 21 | 0.010 |
Why?
|
| Naloxone | 1 | 1992 | 45 | 0.010 |
Why?
|
| Propranolol | 1 | 1992 | 110 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 1992 | 234 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 1995 | 445 | 0.010 |
Why?
|
| Cerebellum | 1 | 1995 | 441 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1991 | 235 | 0.010 |
Why?
|
| Dipeptides | 1 | 1991 | 60 | 0.010 |
Why?
|
| Cross Reactions | 1 | 1991 | 158 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 1995 | 2885 | 0.010 |
Why?
|
| Spinal Cord | 1 | 1991 | 255 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 1991 | 978 | 0.010 |
Why?
|
| Time Factors | 1 | 1994 | 6196 | 0.010 |
Why?
|
| Glutamate Carboxypeptidase II | 1 | 1990 | 6 | 0.010 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1990 | 37 | 0.010 |
Why?
|
| Chromatography, Affinity | 1 | 1990 | 52 | 0.010 |
Why?
|
| Synaptosomes | 1 | 1990 | 19 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 1990 | 64 | 0.010 |
Why?
|
| Antigen-Antibody Complex | 1 | 1990 | 52 | 0.010 |
Why?
|
| Intracellular Membranes | 1 | 1990 | 54 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1990 | 276 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1990 | 254 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1990 | 394 | 0.000 |
Why?
|